http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9412476-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36c9c92fdb0791a5c6d522d25aafbebd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ac9d2c7227488fb874a20f2cf48b34e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e645d353112d475920975d18f63fee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0fd8dd22c0fff36db347006a245b7e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8489f68fbe60f49291440f48ece08c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4668c6ba7c8904c5818b5ae326b5b4f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a552a020dc81db1ad493d5b4aa8fd08c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
filingDate 1993-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a682517dc72b21b17b993360b8273d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745d880ee79f573a0d182436f9b40a80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ae2b8385e6193777211c4428b14bc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb0f7167ec7fa35148ca9232011c2e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08e3ade4124f6d35d93cdb47ff362d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5008706a3d07a2324ab8ac84583927f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd0c653d538594cea2d87e4d9de66b75
publicationDate 1994-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9412476-A1
titleOfInvention Benzanilide derivative
abstract A benzanilide derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, useful for preventing or treating cardiac insuffiency, hyponatremia, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), hypertension, renal insufficiency, edema, water metabolism disorder, and so forth based on arginine vasopressin receptor antagonism. In formula (I), R represents optionally halogenated lower alkyl, hydroxy, lower alkoxy, nitro, amino, mono- or di(lower alkyl)amino, or lower alkanoylamino.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6977254-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7202239-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0129005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7074781-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5696112-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5536718-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5780471-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7109193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7022699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6900200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700796-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6664249-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5719278-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7560454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5521173-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0149682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7064120-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5532235-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5610156-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5654297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20020481-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5612334-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5753648-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880122-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5849735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7326700-B2
priorityDate 1992-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04321669-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9105549-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226418714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129961978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427648

Total number of triples: 57.